Israeli Co.'s $20M Float Sinks Amid Life Science IPO Wave
Israeli biotechnology company PainReform, which develops pain medicines, raised a smaller than expected $20 million to fund clinical trials Tuesday as its shares' price nosedived in their first day of trading...To view the full article, register now.
Already a subscriber? Click here to view full article